Nuvation Bio Balance Sheet Health
Financial Health criteria checks 6/6
Nuvation Bio has a total shareholder equity of $605.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $621.5M and $16.4M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$611.21m |
| Equity | US$605.12m |
| Total liabilities | US$16.36m |
| Total assets | US$621.48m |
Recent financial health updates
We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Sep 14
We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely
Feb 10We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Nov 09Recent updates
Nuvation Bio: Strong Buy Off The Acquisition Of A Late-Stage Lung Cancer Candidate
Mar 31Nuvation: Cash Is King, Science Is An Afterthought
Oct 03We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Sep 14Seth Klarman's Baupost adds Herbalife, Altice USA, exits Dropbox, Enhabit
Feb 14We're Hopeful That Nuvation Bio (NYSE:NUVB) Will Use Its Cash Wisely
Feb 10We Think Nuvation Bio (NYSE:NUVB) Can Afford To Drive Business Growth
Nov 09Nuvation Bio GAAP EPS of -$0.12 beats by $0.02
Nov 03Financial Position Analysis
Short Term Liabilities: NUVB's short term assets ($616.4M) exceed its short term liabilities ($14.0M).
Long Term Liabilities: NUVB's short term assets ($616.4M) exceed its long term liabilities ($2.4M).
Debt to Equity History and Analysis
Debt Level: NUVB is debt free.
Reducing Debt: NUVB currently has no debt however we can't compare to 5 years ago as we have no data for that period.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NUVB has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: NUVB has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 30.2% each year